COVID variables in R&D;Number of employees;Total
Number of enterprises that carry out intramural R&D;Less than 10 employees;2,752
Number of enterprises that carry out intramural R&D;From 10 to 49 employees;4,509
Number of enterprises that carry out intramural R&D;From 50 to 249 employees;2,862
Number of enterprises that carry out intramural R&D;250 and more employees;1,065
Number of enterprises that carry out intramural R&D;Total;11,188
% of companies whose internal R&D expenditure was increased by COVID-19;Less than 10 employees;7.98
% of companies whose internal R&D expenditure was increased by COVID-19;From 10 to 49 employees;7.31
% of companies whose internal R&D expenditure was increased by COVID-19;From 50 to 249 employees;5.51
% of companies whose internal R&D expenditure was increased by COVID-19;250 and more employees;5.67
% of companies whose internal R&D expenditure was increased by COVID-19;Total;6.86
% of companies whose internal R&D expenditure was decreased by COVID-19;Less than 10 employees;30.45
% of companies whose internal R&D expenditure was decreased by COVID-19;From 10 to 49 employees;27.20
% of companies whose internal R&D expenditure was decreased by COVID-19;From 50 to 249 employees;26.20
% of companies whose internal R&D expenditure was decreased by COVID-19;250 and more employees;29.33
% of companies whose internal R&D expenditure was decreased by COVID-19;Total;27.95
% of companies that performed internal R&D related to COVID-19;Less than 10 employees;7.96
% of companies that performed internal R&D related to COVID-19;From 10 to 49 employees;8.25
% of companies that performed internal R&D related to COVID-19;From 50 to 249 employees;8.25
% of companies that performed internal R&D related to COVID-19;250 and more employees;11.01
% of companies that performed internal R&D related to COVID-19;Total;8.44
Total expenditure on internal R&D related to COVID-19;Less than 10 employees;8,106
Total expenditure on internal R&D related to COVID-19;From 10 to 49 employees;23,155
Total expenditure on internal R&D related to COVID-19;From 50 to 249 employees;39,162
Total expenditure on internal R&D related to COVID-19;250 and more employees;58,852
Total expenditure on internal R&D related to COVID-19;Total;129,275